Xperix Plans to Sell All Xplus Convertible Bonds Over-the-Counter - Liquidity Purpose with Potential Dilution Concerns
Xperix, as the de facto controlling shareholder, disclosed a plan to sell all remaining 3,570,242 shares of Xplus 4th convertible bonds over-the-counter on July 30, 2026.
The purpose is to secure cash liquidity through the sale, with a transaction amount of approximately 10.75 billion KRW based on a conversion price of 3,011 KRW.
These convertible bonds represent a potential dilution of about 14.26% relative to total outstanding shares, and if converted after the sale, they could impact existing shareholder value.
Considering the recent sale of convertible bonds totaling 4.22 billion KRW in the past six months, the major shareholder's ongoing cash-out moves may weigh on short-term stock prices.
[AI Summary]The plan to sell all convertible bonds by Xperix aims to secure liquidity but raises concerns over potential dilution and insider cash-out, while the opaque counterparty and terms add information asymmetry risk.
KOSDAQ Filing Information
Report On Transaction Plan Of Specific Securities By Executives And Major Shareholders